About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Ohio | 987 Studies

Clinical Trials Breast CancerOhio

Breast Cancer Clinical Trials in Ohio

Find 987 clinical trials for breast cancer near Ohio. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 941-960 of 987 trials

Active not recruitingNeoadjuvant Carboplatin and Docetaxel in Triple Negative Breast CancerThe purpose of this study is to determine whether the combination of docetaxel and carboplatin is an effective treatment for patients with triple negative breast cancer.NCT02547987·Cincinnati, Ohio and 2 others CompletedPhase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorThis study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant…NCT01610284·Mobile, Alabama and 267 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerRSR13 (efaproxiral) is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases.NCT00083304·Phoenix, Arizona and 93 others

UnknownCircadian Thermal Sensing to Detect Breast DiseaseThe purpose of this study is to determine if Cyrcadia's Circadian Biometric Recorder (CBR™), which is attached to soft biometric patches worn on the body, can improve early breast…NCT02511301·Mountain View, California and 1 other

RecruitingA Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast CancerThis first-in-human, open-label, multicenter study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of PRT13722, an…NCT07905001·Tamarac, Florida and 2 others

CompletedThe Incidence of Breast and Other Cancers Among Female Flight AttendantsFlight attendants may be at an increased risk of breast and other cancers due to work-place exposures including cosmic radiation and circadian rhythm disruption form traveling…NCT00342407·Cincinnati, Ohio

CompletedStudy of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast CancerThe main purpose of this study is to see whether CDX-011 (glembatumumab vedotin, an antibody-drug conjugate) is effective in treating patients who have advanced Triple-Negative…NCT01997333·Birmingham, Alabama and 139 others

CompletedA Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)This 2-arm, randomized, open-label study will evaluate the efficacy and safety of trastuzumab emtansine versus trastuzumab as adjuvant therapy in patients with HER2-positive…NCT01772472·Anchorage, Alaska and 267 others

CompletedPsychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerThis randomized phase II trial studies how well psychosexual intervention works in patients with stage I-III gynecologic or breast cancer.NCT01764802·Columbus, Ohio

RecruitingA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional…NCT05824975·Scottsdale, Arizona and 10 others

Active not recruitingMetformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast CancerThis phase III trial studies how well metformin hydrochloride works compared to placebo in preventing breast cancer in patients with atypical hyperplasia or in situ breast cancer.NCT01905046·Duarte, California and 26 others

CompletedCompliance to a Hormone Therapy Regimen in Breast CancerRATIONALE: Understanding how well patients comply with their treatment regimen may help doctors plan the best treatment and ongoing care.NCT00666822·Cleveland, Ohio

CompletedStudy Evaluating SKI-606 (Bosutinib) In Subjects With Breast CancerThe purpose of this study is to determine if SKI-606 (Bosutinib) is effective in the treatment of advanced or metastatic breast cancer.NCT00319254·Duarte, California and 14 others

RecruitingA Study of BTX-A51 in People With Advanced Solid Tumor and Breast CancerThis is a multicenter, open label, nonrandomized, sequential dose escalation/dose ranging, multiple dose study designed to evaluate the safety, toxicity, and PK as well as…NCT04872166·Lake Mary, Florida and 5 others

Active not recruitingPhase IIB Trial of Bazedoxifene Plus Conjugated EstrogensWomen at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE)…NCT04821141·Duarte, California and 5 others

CompletedA Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk WomenThis clinical trial tests whether a new dietary pattern that consists of foods that lower the blood insulin response can reduce breast cancer risk in high-risk women.NCT06635005·Columbus, Ohio

CompletedSafety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerThe purpose of this study is to assess safety of nab-paclitaxel based chemotherapy regimens administered prior to and/or in combination with nivolumab in Pancreatic Cancer, Non…NCT02309177·Sacramento, California and 14 others

CompletedMagnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast CancerRATIONALE: Magnesium oxide may help relieve hot flashes symptoms in women with a history of breast cancer.NCT01439945·Fairbanks, Alaska and 282 others

CompletedExemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerRATIONALE: High estrogen levels may be associated with dense breast tissue and an increased risk of developing breast cancer.NCT00066586·Jacksonville, Florida and 11 others

CompletedT-DM1 and Palbociclib for Metastatic HER2 Breast CancerThis is a single arm, phase II study to evaluate if the combination of T-DM1 with palbociclib improves progression-free survival in patients with metastatic HER2 positive breast…NCT03530696·Tucson, Arizona and 15 others

PreviousPage 48 of 50Next

Other Conditions in Ohio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma